Financing - March 3, 2020
Scandion Oncology receives DKK 5 million
Scandion Oncology A/S has obtained DKK 5 million from Innovation Fund Denmark for the clinical development of SCO-101 in metastatic pancreatic cancer. The grant of DKK 5 million from Innovation Fund Denmark is earmarked for the clinical phase II development of SCO-101 in metastatic pancreatic cancer. “We are very pleased to receive this soft money […]
Financing - February 27, 2020
AlgoDx raises 6 million SEK
AlgoDx, which focuses on supporting disease detection and prediction with machine learning algorithms, has closed a 6 million SEK seed round led by Nascent Invest with participation from angel investors Fredrik Sjödin and Tomas Mora-Morrison, co-founder of Cambio Healthcare Systems. AlgoDx’s first product, ExPRESS, has been developed to autonomously predict sepsis in hospitalized patients using […]
Clinical Trials - February 20, 2020
Scandinavian Biopharma secures 10.6 million EUR
Scandinavian Biopharma has been awarded a 10.6 million EUR grant from EDCTP in international competition for the planned Phase III clinical trial of the ETEC vaccine candidate ETVAX. The EDCTP grant is a part of the European Framework Programme for Research and Innovation, Horizon 2020. Make the vaccine preparation more fieldable and user-friendly The project […]
Financing - February 20, 2020
Cantargia completes a directed share issue of approximately 410 million SEK
Through the Directed Share Issue, Cantargia will receive proceeds amounting to approximately SEK 410 million before transaction related costs. Investors in the Directed Share Issue are a wide range of Swedish and international investors including new investors such as Swedbank Robur, HBM Healthcare Investments, Granite Point Capital and Unionen as well as current shareholders such […]
Financing - February 19, 2020
15 million SEK invested in MediTuner
15 million SEK has been invested in MediTuners’s digital asthma-app. Almi Invest is investing 3 million SEK in MediTuner and its app AsthmaTuner, developed together with Karolinska Institutet. The app is connected to a spirometry and provides asthma patients with an automatic treatment recommendation. In this emission consisting of 15 million SEK a number of […]
Financing - February 10, 2020
Chinese investment in Betagenon
Chinese investment firm Ivy Capital is investing almost three million USD into Umeå-based biotechnology firm Betagenon. Betagenon has identified an enzyme activator that is intended as a drug candidate for multiple lifestyle and age disorders such as diabetes and heart failure. Ivy Capital is now investing SEK 28.5 million into Betagenon to help support clinical […]
